tradingkey.logo

Biomerica Inc

BMRA
查看详细走势图
2.650USD
+0.030+1.15%
收盘 12/24, 13:00美东报价延迟15分钟
7.46M总市值
亏损市盈率 TTM

Biomerica Inc

2.650
+0.030+1.15%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.15%

5天

+10.88%

1月

+15.72%

6月

-16.14%

今年开始到现在

+10.38%

1年

+19.15%

查看详细走势图

TradingKey Biomerica Inc股票评分

单位: USD 更新时间: 2025-12-24

操作建议

Biomerica Inc当前公司基本面数据相对非常健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名150/206位。机构持股占比非常高,中期看,股价处于平稳状态。近一个月,市场表现较强,但基本面和技术面综合得分较低,较强的走势没有得到基本面和技术面印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Biomerica Inc评分

相关信息

行业排名
150 / 206
全市场排名
445 / 4562
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
--
目标均价
--
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Biomerica Inc亮点

亮点风险
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
业绩增长期
公司处于发展阶段,最新年度总收入5.31M美元
估值合理
公司最新PE估值-1.72,处于3年历史合理位
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值21.13K
活跃度增加
近期活跃度增加,过去20天平均换手率0.18

Biomerica Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Biomerica Inc简介

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
公司代码BMRA
公司Biomerica Inc
CEOIrani (Zackary S)
网址https://biomerica.com/

常见问题

Biomerica Inc(BMRA)的当前股价是多少?

Biomerica Inc(BMRA)的当前股价是 2.650。

Biomerica Inc的股票代码是什么?

Biomerica Inc的股票代码是BMRA。

Biomerica Inc股票的52周最高点是多少?

Biomerica Inc股票的52周最高点是10.160。

Biomerica Inc股票的52周最低点是多少?

Biomerica Inc股票的52周最低点是2.110。

Biomerica Inc的市值是多少?

Biomerica Inc的市值是7.46M。

Biomerica Inc的净利润是多少?

Biomerica Inc的净利润为-4.97M。

现在Biomerica Inc(BMRA)的股票是买入、持有还是卖出?

根据分析师评级,Biomerica Inc(BMRA)的总体评级为--,目标价格为--。

Biomerica Inc(BMRA)股票的每股收益(EPS TTM)是多少

Biomerica Inc(BMRA)股票的每股收益(EPS TTM)是-1.538。
KeyAI